Zepp Health Corp
NYSE:ZEPP
Zepp Health Corp
NYSE:ZEPP
Price:
0.8903 USD
-2.16%
Market Closed
Updated:
May 3, 2024
Balance Sheet
Balance Sheet Decomposition
Zepp Health Corp
Zepp Health Corp
| Current Assets | 2.5B |
| Cash & Short-Term Investments | 952.8m |
| Receivables | 578.9m |
| Other Current Assets | 972.6m |
| Non-Current Assets | 2.3B |
| Long-Term Investments | 1.7B |
| PP&E | 111.6m |
| Intangibles | 174.8m |
| Other Non-Current Assets | 346m |
| Current Liabilities | 1.2B |
| Accounts Payable | 479.8m |
| Accrued Liabilities | 152.6m |
| Short-Term Debt | 566.4m |
| Other Current Liabilities | 23.8m |
| Non-Current Liabilities | 1.1B |
| Long-Term Debt | 861.4m |
| Other Non-Current Liabilities | 225m |
Balance Sheet
Zepp Health Corp
Zepp Health Corp
Currency: CNY
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
220
|
153
|
366
|
1 539
|
1 803
|
2 278
|
1 474
|
887
|
|
| Cash Equivalents |
220
|
153
|
366
|
1 539
|
1 803
|
2 278
|
1 474
|
887
|
|
| Short-Term Investments |
0
|
9
|
14
|
51
|
17
|
18
|
19
|
34
|
|
| Total Receivables |
206
|
499
|
641
|
758
|
1 664
|
1 280
|
1 088
|
870
|
|
| Accounts Receivables |
195
|
496
|
611
|
715
|
1 610
|
1 158
|
833
|
821
|
|
| Other Receivables |
11
|
2
|
30
|
42
|
54
|
122
|
255
|
50
|
|
| Inventory |
90
|
192
|
250
|
485
|
894
|
1 218
|
1 249
|
1 022
|
|
| Other Current Assets |
4
|
6
|
25
|
26
|
14
|
34
|
101
|
145
|
|
| Total Current Assets |
520
|
860
|
1 295
|
2 858
|
4 393
|
4 828
|
3 931
|
2 959
|
|
| PP&E Net |
3
|
11
|
29
|
40
|
173
|
276
|
242
|
166
|
|
| PP&E Gross |
3
|
11
|
29
|
40
|
173
|
276
|
242
|
166
|
|
| Accumulated Depreciation |
0
|
3
|
6
|
12
|
21
|
36
|
71
|
112
|
|
| Intangible Assets |
0
|
1
|
5
|
64
|
86
|
145
|
136
|
123
|
|
| Goodwill |
0
|
0
|
6
|
6
|
6
|
63
|
61
|
66
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Long-Term Investments |
2
|
78
|
85
|
209
|
406
|
444
|
1 553
|
1 687
|
|
| Other Long-Term Assets |
5
|
23
|
45
|
82
|
112
|
148
|
163
|
261
|
|
| Other Assets |
0
|
0
|
6
|
6
|
6
|
63
|
61
|
66
|
|
| Total Assets |
529
N/A
|
973
+84%
|
1 466
+51%
|
3 259
+122%
|
5 175
+59%
|
5 904
+14%
|
6 086
+3%
|
5 268
-13%
|
|
| Liabilities | |||||||||
| Accounts Payable |
260
|
548
|
716
|
1 075
|
2 015
|
1 963
|
1 367
|
498
|
|
| Accrued Liabilities |
14
|
33
|
62
|
154
|
256
|
135
|
140
|
93
|
|
| Short-Term Debt |
0
|
13
|
35
|
39
|
2
|
505
|
462
|
968
|
|
| Other Current Liabilities |
4
|
41
|
64
|
120
|
209
|
188
|
183
|
110
|
|
| Total Current Liabilities |
278
|
634
|
877
|
1 388
|
2 482
|
2 790
|
2 152
|
1 669
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
60
|
727
|
684
|
|
| Deferred Income Tax |
0
|
0
|
3
|
5
|
5
|
22
|
27
|
36
|
|
| Minority Interest |
0
|
0
|
2
|
1
|
3
|
0
|
13
|
12
|
|
| Other Liabilities |
0
|
0
|
8
|
56
|
190
|
301
|
246
|
194
|
|
| Total Liabilities |
278
N/A
|
634
+128%
|
890
+40%
|
1 448
+63%
|
2 674
+85%
|
3 174
+19%
|
3 165
0%
|
2 595
-18%
|
|
| Equity | |||||||||
| Common Stock |
272
|
308
|
350
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
60
|
37
|
131
|
340
|
911
|
1 133
|
1 271
|
943
|
|
| Additional Paid In Capital |
29
|
51
|
72
|
1 374
|
1 479
|
1 552
|
1 642
|
1 691
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
22
|
67
|
|
| Other Equity |
10
|
16
|
22
|
97
|
111
|
45
|
29
|
106
|
|
| Total Equity |
251
N/A
|
339
+35%
|
575
+70%
|
1 811
+215%
|
2 501
+38%
|
2 730
+9%
|
2 920
+7%
|
2 673
-8%
|
|
| Total Liabilities & Equity |
529
N/A
|
973
+84%
|
1 466
+51%
|
3 259
+122%
|
5 175
+59%
|
5 904
+14%
|
6 086
+3%
|
5 268
-13%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
238
|
238
|
238
|
242
|
248
|
250
|
251
|
251
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
